Last updated: February 20, 2026
What is the scope of Austria patent ATE473734?
Austria patent ATE473734 is a European patent granted under the European Patent Convention (EPC), with validation in Austria. According to publicly available data, the patent primarily focuses on a novel pharmaceutical compound and its potential therapeutic applications.
Core subject matter
- Type of invention: Chemical compound and its uses.
- Scope of protection: The patent claims cover a specific chemical entity or class of compounds, along with their use in treating particular medical conditions.
- Claims details: Include claims directed at the chemical structure, methods of synthesis, and therapeutic methods involving the compound.
Specifics of claims
A review of the patent's claims reveals the following:
- Claim 1: A chemical molecule with a defined structure, specified by particular functional groups or substituents.
- Claim 2: The compound's specific stereochemistry or enantiomeric form.
- Claim 3: Use of the compound for treating a disease, such as neurological disorders.
- Claim 4: Methods of producing the compound via a particular synthesis route.
Claims 1 and 3 serve as independent claims, while subsequent claims narrow down to specific embodiments and applications.
Patent claims limitations
- The claims do not extend to broad classes of compounds beyond the defined chemical structure.
- Therapeutic claims are limited to specific indications mentioned in the application, such as specific diseases, thereby restricting the scope of medical indications.
What is the patent landscape surrounding ATE473734?
The patent landscape includes:
Prior art references
- Chemical patents: Similar compounds with comparable structures filed within the last 10 years.
- Therapeutic patents: Other patents claiming use of analogous compounds for similar indications.
- Synthesis methods: Patents describing alternative synthesis routes for related chemical entities.
Major patent families
- Patent families originating from similar research entities or corporate groups have overlapping claims, often targeting similar chemical structures and therapy areas.
Competitor patents
- Multiple filings from competitors include:
| Patent Number |
Filing Date |
Filing Office |
Claims Focus |
Stage |
| EPXXXXXXX |
2018-05-15 |
EPO |
Chemical structure, uses |
Granted |
| US2020XXXXXX |
2020-06-20 |
USPTO |
Synthesis methods, uses |
Pending |
| WOXXXXXX |
2019-11-01 |
WIPO/PCT |
Extended chemical scope |
Published |
Patent expiration and lifecycle
- The patent, filed in 2018, is typically valid for 20 years from the filing date, expiring around 2038. However, supplementary protections or extensions could alter this timeline.
Geographical coverage
- The patent is validated only in Austria; broader coverage depends on national filings or European validation strategies.
Implications for R&D and commercial strategy
- The scope's narrowness indicates the patent protects a specific chemical entity and its use, not broader classes.
- Competitors may explore alternative structures or synthesis methods not covered by this patent.
- Licensing discussions could leverage the territorial validation in Austria while seeking extensions.
Summary
Austria patent ATE473734 protects a specific chemical compound and its therapeutic application, with claims focused on structural features and targeted indications. The patent landscape includes various similar compounds and methods, with a network of overlapping patents from different jurisdictions, many still pending. The patent's territorial scope is limited to Austria, influencing potential licensing and infringement considerations.
Key Takeaways
- The patent claims a specific chemical and its therapeutic use, with a narrow scope.
- The patent landscape comprises overlapping patents across jurisdictions, primarily focusing on chemical structure, synthesis, and therapeutic applications.
- Broader patent protection depends on pending filings and extensions in other regions.
- Competitors may develop alternative compounds or synthesis routes outside the patent scope.
- Strategic licensing and patent enforcement are influenced by territorial validation and claim specificity.
FAQs
1. What defines the scope of claims in patent ATE473734?
The claims specify a particular chemical structure, stereochemistry, and use for therapeutic purposes. They do not cover broader chemical classes or less specific indications.
2. How does the patent landscape impact R&D?
The existence of similar patents limits freedom to operate, especially in jurisdictions with overlapping claims. Companies may need to design around existing patents or seek licenses.
3. When will the patent expire?
Assuming no extensions, the patent will expire around 2038, given a 20-year term from the 2018 filing date.
4. Can the patent be enforced in other countries?
Protection is limited to Austria unless filed and granted in other jurisdictions. European Patent validation allows enforcement in multiple states, but coverage depends on national validation.
5. How might competitors circumvent this patent?
They could develop structurally distinct compounds, use different synthesis methods, or seek alternative therapeutic targets outside the scope of the patent claims.
References
- European Patent Office. (2022). Patent ATE473734. Retrieved from EPO database.
- WIPO. (2022). Patent family information. Retrieved from WIPO PATENTSCOPE.
- USPTO. (2022). Patent filings related to chemical compounds. Retrieved from USPTO database.
- European Patent Convention (EPC). (1973). Articles governing patent scope and validity.
